BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to Income Statement
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Consolidated Net Profit History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-17 Cr | ₹-8.75 Cr | ₹-18 Cr | ₹-10 Cr | ₹-5.79 Cr |
What is the latest Consolidated Net Profit of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹-17 Cr |
Mar2022 | ₹-8.75 Cr |
Mar2021 | ₹-18 Cr |
Mar2020 | ₹-10 Cr |
Mar2019 | ₹-5.79 Cr |
How is Consolidated Net Profit of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹-17 Cr | Negative | |
Mar2022 | ₹-8.75 Cr | Negative | |
Mar2021 | ₹-18 Cr | Negative | |
Mar2020 | ₹-10 Cr | Negative | |
Mar2019 | ₹-5.79 Cr | - |
Compare Consolidated Net Profit of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹130.0 Cr | -4.4% | -6.7% | 26.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.9% | -6.6% | 58.8% | Stock Analytics | |
CIPLA | ₹112,058.0 Cr | -1% | -5.6% | 54.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.9% | 2.2% | 27.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,845.0 Cr | -2.2% | 6.2% | 21.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 2.8% | -0.6% | 96.2% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -4.4% |
-6.7% |
26.8% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses